$1.53 Earnings Per Share Expected for CME Group Inc (CME) This Quarter

Brokerages forecast that CME Group Inc (NASDAQ:CME) will post earnings per share of $1.53 for the current quarter, according to Zacks. Four analysts have issued estimates for CME Group’s earnings, with estimates ranging from $1.49 to $1.55. CME Group reported earnings per share of $1.22 during the same quarter last year, which suggests a positive year-over-year growth rate of 25.4%. The company is scheduled to issue its next earnings results on Thursday, April 26th.

According to Zacks, analysts expect that CME Group will report full-year earnings of $6.32 per share for the current financial year, with EPS estimates ranging from $6.05 to $6.86. For the next year, analysts expect that the business will report earnings of $6.73 per share, with EPS estimates ranging from $6.40 to $7.00. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side analysts that follow CME Group.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.12 EPS for the quarter, beating analysts’ consensus estimates of $1.10 by $0.02. The company had revenue of $900.00 million during the quarter, compared to analysts’ expectations of $886.85 million. CME Group had a return on equity of 7.68% and a net margin of 111.49%. CME Group’s revenue was down 1.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.14 EPS.

Several brokerages recently issued reports on CME. Barclays boosted their price objective on CME Group from $170.00 to $175.00 and gave the company an “overweight” rating in a research report on Friday, February 2nd. Bank of America boosted their price objective on CME Group from $173.00 to $175.00 and gave the company a “buy” rating in a research report on Friday, February 2nd. Sandler O’Neill reiterated a “buy” rating and issued a $175.00 price objective on shares of CME Group in a research report on Friday, February 2nd. Goldman Sachs Group upgraded CME Group from a “neutral” rating to a “buy” rating and set a $180.00 price objective for the company in a research report on Wednesday, February 7th. Finally, BidaskClub upgraded CME Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 10th. Three equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $157.00.

Shares of CME Group (NASDAQ:CME) traded up $3.49 on Wednesday, hitting $164.02. The company had a trading volume of 972,314 shares, compared to its average volume of 2,007,399. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.03 and a quick ratio of 1.05. CME Group has a 1-year low of $114.82 and a 1-year high of $165.35. The firm has a market cap of $54,438.13, a price-to-earnings ratio of 13.74, a PEG ratio of 2.08 and a beta of 0.64.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 26th. Stockholders of record on Friday, March 9th will be paid a dividend of $0.70 per share. The ex-dividend date is Thursday, March 8th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.71%. This is a boost from CME Group’s previous quarterly dividend of $0.66. CME Group’s dividend payout ratio is currently 22.11%.

In related news, Chairman Terrence A. Duffy sold 20,000 shares of the stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $151.66, for a total value of $3,033,200.00. Following the sale, the chairman now owns 99,239 shares in the company, valued at approximately $15,050,586.74. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Ronald A. Pankau sold 200 shares of the stock in a transaction on Wednesday, February 14th. The shares were sold at an average price of $159.91, for a total value of $31,982.00. Following the completion of the sale, the director now owns 3,809 shares in the company, valued at approximately $609,097.19. The disclosure for this sale can be found here. In the last quarter, insiders have sold 68,027 shares of company stock worth $10,294,709. Company insiders own 0.57% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the stock. ARK Investment Management LLC bought a new stake in CME Group in the 4th quarter valued at $120,000. Valeo Financial Advisors LLC bought a new position in CME Group during the 3rd quarter worth $124,000. AlphaOne Investment Services LLC bought a new position in CME Group during the 4th quarter worth $146,000. Mosaic Family Wealth LLC bought a new position in CME Group during the 4th quarter worth $146,000. Finally, Truewealth LLC bought a new position in CME Group during the 4th quarter worth $157,000. Institutional investors and hedge funds own 82.63% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This story was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another website, it was illegally copied and republished in violation of US and international copyright and trademark laws. The original version of this story can be accessed at https://www.dispatchtribunal.com/2018/02/24/1-53-earnings-per-share-expected-for-cme-group-inc-cme-this-quarter.html.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply